Asia Pacific Flow Cytometry Market Size & Outlook
Asia Pacific flow cytometry market, 2018-2030 (US$M)
Related Markets
Asia Pacific flow cytometry market highlights
- The Asia Pacific flow cytometry market generated a revenue of USD 961.1 million in 2023.
- The market is expected to grow at a CAGR of 8.1% from 2024 to 2030.
- In terms of segment, instruments was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 961.1 million |
| Market revenue in 2030 | USD 1,656.6 million |
| Growth rate | 8.1% (CAGR from 2023 to 2030) |
| Largest segment | Instruments |
| Fastest growing segment | Software |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & Consumables, Software, Accessories, Services |
| Key market players worldwide | Danaher Corp, BD, Sysmex Corp, Agilent Technologies, Apogee Enterprises Inc, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Wipro Ltd ADR, Diasorin SpA, Miltenyi Biotec, Sony Group Corp |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 22.3% of the global flow cytometry market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,656.6 million by 2030.
Instruments was the largest segment with a revenue share of 35.98% in 2023. Horizon Databook has segmented the Asia Pacific flow cytometry market based on instruments, reagents & consumables, software, accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is expected to grow at an exponential CAGR during the forecast period. This high growth can be attributed to the extensive growth in pharmaceutical and biotechnology industries of emerging economies, such as China & India. This region's profitable expansion is also attributed to ongoing government backing for the development of the pharmaceutical sector in developing countries.
Moreover, ongoing Innovations in the fields of cancer & infectious illnesses, such as COVID-19, are expected to drive significant growth for flow cytometry market in the region. The Asia Pacific flow cytometry market is driven by growing incidence of chronic diseases and increasing use of cytometry devices in various applications.
Furthermore, increased cost of flow cytometry equipment and limitations of flow cytometry are projected to impede market expansion. The Asia Pacific market may benefit from increased acceptance of flow cytometry technologies in research & academia, broad development in the biopharmaceutical industry, and strategic initiatives undertaken by industry leaders.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Flow Cytometry Market Scope
Flow Cytometry Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific flow cytometry market size, by country, 2018-2030 (US$M)
Asia Pacific Flow Cytometry Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
